Biofilm-associated chronic infections are notoriously recalcitrant and exceedingly tolerant to antibiotic treatments. It is thought that the biofilm matrix, a hydrated layer or polysaccharides, proteins and nucleic acids that surrounds microbes in a biofilm, is a primary driver of chronicity and tolerance during infection. We hypothesized that by degrading these matrix components, we can expose the microbes inside the biofilm and increase antibiotic efficacy. Here I will discuss our pre-clinical evaluation of polysaccharide-degrading enzymes for wound infections, and what we have learned about the biofilm matrix of Pseudomonas aeruginosa during infection.
Presenter(s)
Once the content has been viewed and you have attested to it, you will be able to download and print a certificate for PDH credits.
If you have already viewed this content,
please click here
to login.